Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Arteris, Inc.AIP · Entity 2399 | VP and General Counsel | October 05, 2026 | October 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Arteris, Inc.
Report date October 05, 2026 · Filed October 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 61,082 |
Reported balance
After 2026-10-05 transaction · row 1
1 source rowRow 1 · 2026-10-05 · Sale · Disposed 6,003 · Balance 61,082 F1: Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on February 23, 2026. F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.92 to $24.70 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on February 23, 2026.
F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.92 to $24.70 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 17, 2022 Filed May 19, 2022 23:54 UTC | Arteris, Inc. AIP · Entity 2399 | SaleCommon Stock | 904 | $8.08 | $7,308.03 |
DisclosureSEC source: 0001567619-22-011339 · doc1.xml · nonDerivative · entry 1 Alpern Paul L · CIK 0001888542 · VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,552 F1 · kind: Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $7.89 to $8.35 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 02, 2022 Filed May 4, 2022 23:49 UTC | Arteris, Inc. AIP · Entity 2399 | Tax withholdingCommon Stock | 460 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-009529 · doc1.xml · nonDerivative · entry 1 Alpern Paul L · CIK 0001888542 · VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,456 F1 · balance_after: Includes 10,456 restricted stock units. Read SEC document |
| November 11, 2021 Filed Nov 19, 2021 23:57 UTC | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 10,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-020900 · doc1.xml · nonDerivative · entry 1 Alpern Paul L · CIK 0001888542 · VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,941 F1 · shares: Includes 10,941 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest with respect to 12.5% of the total RSUs on 5/1/2022 and in equal quarterly installments thereafter. The RSUs have no expiration date. F2 · balance_after: Includes 10,941 restricted stock units. Read SEC document |
| November 11, 2021 Filed Jan 14, 2022 22:48 UTC Amendment | Arteris, Inc. AIP · Entity 2399 | GrantCommon Stock | 10,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-001213 · doc1.xml · nonDerivative · entry 1 Alpern Paul L · CIK 0001888542 · VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,916 F1 · shares: The original form 4 inadvertently overstated the number of restricted stock units ("RSUs") awarded. This amendment is being filed to correctly report the number of RSUs earned and the total number of shares beneficially owned following the reported transaction. Reflects 10,916 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest with respect to 12.5% of the total RSUs on 5/1/2022 and in equal quarterly installments thereafter. The RSUs have no expiration date. F2 · balance_after: Includes 10,916 restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.